251 related articles for article (PubMed ID: 24916746)
1. Surgical resection after down-staging of locally advanced hepatocellular carcinoma by localized concurrent chemoradiotherapy.
Lee HS; Choi GH; Choi JS; Kim KS; Han KH; Seong J; Ahn SH; Kim DY; Park JY; Kim SU; Kim BK
Ann Surg Oncol; 2014 Oct; 21(11):3646-53. PubMed ID: 24916746
[TBL] [Abstract][Full Text] [Related]
2. Downstaging with Localized Concurrent Chemoradiotherapy Can Identify Optimal Surgical Candidates in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Chong JU; Choi GH; Han DH; Kim KS; Seong J; Han KH; Choi JS
Ann Surg Oncol; 2018 Oct; 25(11):3308-3315. PubMed ID: 30083834
[TBL] [Abstract][Full Text] [Related]
3. Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma.
Kim BK; Ahn SH; Seong JS; Park JY; Kim DY; Kim JK; Lee DY; Lee KH; Han KH
Liver Int; 2011 Mar; 31(3):369-76. PubMed ID: 21083802
[TBL] [Abstract][Full Text] [Related]
4. Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma.
Han S; Choi HJ; Beom SH; Kim HR; Lee H; Lee JS; Lee HW; Park JY; Kim SU; Kim DY; Ahn SH; Han KH; Seong J; Won JY; Kim BK
J Cancer Res Clin Oncol; 2021 Oct; 147(10):3123-3133. PubMed ID: 33893539
[TBL] [Abstract][Full Text] [Related]
5. Hepatectomy after down-staging of hepatocellular carcinoma with portal vein tumor thrombus using chemoradiotherapy: A retrospective cohort study.
Hamaoka M; Kobayashi T; Kuroda S; Iwako H; Okimoto S; Kimura T; Aikata H; Nagata Y; Chayama K; Ohdan H
Int J Surg; 2017 Aug; 44():223-228. PubMed ID: 28676383
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of hepatic arterial infusion chemotherapy in combination with irradiation for advanced hepatocellular carcinoma with portal vein invasion.
Onishi H; Nouso K; Nakamura S; Katsui K; Wada N; Morimoto Y; Miyahara K; Takeuchi Y; Kuwaki K; Yasunaka T; Miyake Y; Shiraha H; Takaki A; Kobayashi Y; Sakaguchi K; Kanazawa S; Yamamoto K
Hepatol Int; 2015 Jan; 9(1):105-12. PubMed ID: 25788384
[TBL] [Abstract][Full Text] [Related]
7. Early on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma.
Lee MH; Kim SU; Kim DY; Ahn SH; Choi EH; Lee KH; Lee DY; Seong J; Han KH; Chon CY; Park JY
J Gastroenterol Hepatol; 2012 Feb; 27(2):313-22. PubMed ID: 21793906
[TBL] [Abstract][Full Text] [Related]
8. Role and limitation of neoadjuvant hepatic arterial infusion chemotherapy in advanced hepatocelluar carcinoma patients with Child-Pugh class A.
Lee BH; Lee DS; Cho CW; Yun SS
World J Surg Oncol; 2019 Aug; 17(1):143. PubMed ID: 31416447
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes and prognostic factors with reductive hepatectomy and sequential percutaneous isolated hepatic perfusion for multiple bilobar hepatocellular carcinoma.
Fukumoto T; Tominaga M; Kido M; Takebe A; Tanaka M; Kuramitsu K; Matsumoto I; Ajiki T; Ku Y
Ann Surg Oncol; 2014 Mar; 21(3):971-8. PubMed ID: 24201744
[TBL] [Abstract][Full Text] [Related]
10. Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy.
Han DH; Joo DJ; Kim MS; Choi GH; Choi JS; Park YN; Seong J; Han KH; Kim SI
Yonsei Med J; 2016 Sep; 57(5):1276-81. PubMed ID: 27401662
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant hepatic arterial infusion chemotherapy is beneficial for selective patients with Hepatocellular carcinoma undergoing surgical treatment.
Hsiao JH; Tsai CC; Liang TJ; Chiang CL; Liang HL; Chen IS; Chen YC; Chang PM; Chou NH; Wang BW
Int J Surg; 2017 Sep; 45():35-41. PubMed ID: 28728985
[TBL] [Abstract][Full Text] [Related]
12. Transarterial Radioembolization Versus Concurrent Chemoradiation Therapy for Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
Song JE; Jung KS; Kim DY; Song K; Won JY; Lee HW; Kim BK; Kim SU; Park JY; Ahn SH; Seong J; Han KH
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):396-406. PubMed ID: 28871990
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant hepatic arterial infusion chemotherapy after radical hepatectomy for hepatocellular carcinoma--results of long-term follow-up.
Asahara T; Itamoto T; Katayama K; Ono E; Dohi K; Nakanishi T; Kitamoto M; Azuma K; Ito K
Hepatogastroenterology; 1999; 46(26):1042-8. PubMed ID: 10370664
[TBL] [Abstract][Full Text] [Related]
14. Hepatic Resection for Hepatocellular Carcinoma with Tumor Thrombus in the Major Portal Vein.
Kojima H; Hatano E; Taura K; Seo S; Yasuchika K; Uemoto S
Dig Surg; 2015; 32(6):413-20. PubMed ID: 26316188
[TBL] [Abstract][Full Text] [Related]
15. Changing trends in long-term outcomes after hepatic resection for hepatocellular carcinoma: A 30-year, single-center experience.
Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
Anticancer Res; 2013 Nov; 33(11):5097-105. PubMed ID: 24222155
[TBL] [Abstract][Full Text] [Related]
16. Debulking surgery followed by intraarterial 5-fluorouracil chemotherapy plus subcutaneous interferon alfa for massive hepatocellular carcinoma with multiple intrahepatic metastases: a pilot study.
Tanaka K; Yabushita Y; Nakagawa K; Kumamoto T; Matsuo K; Taguri M; Endo I
Eur J Surg Oncol; 2013 Dec; 39(12):1364-70. PubMed ID: 24183169
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of ¹⁸F-FDG Uptake in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization or Concurrent Chemoradiotherapy: A Multicenter Retrospective Cohort Study.
Lee JW; Oh JK; Chung YA; Na SJ; Hyun SH; Hong IK; Eo JS; Song BI; Kim TS; Kim DY; Kim SU; Moon DH; Lee JD; Yun M
J Nucl Med; 2016 Apr; 57(4):509-16. PubMed ID: 26742711
[TBL] [Abstract][Full Text] [Related]
18. Concurrent chemoradiotherapy shows long-term survival after conversion from locally advanced to resectable hepatocellular carcinoma.
Lee IJ; Kim JW; Han KH; Kim JK; Kim KS; Choi JS; Park YN; Seong J
Yonsei Med J; 2014 Nov; 55(6):1489-97. PubMed ID: 25323884
[TBL] [Abstract][Full Text] [Related]
19. Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma.
Cha H; Yoon HI; Lee IJ; Koom WS; Han KH; Seong J
J Radiat Res; 2013 Nov; 54(6):1069-77. PubMed ID: 23633620
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting survival after concurrent chemoradiation therapy for advanced hepatocellular carcinoma: a retrospective study.
Kim JK; Kim JW; Lee IJ; Joo SM; Lee KH; Cho ES; Yu JS; Jeon TJ; Kim Y; Lee JI; Lee KS
Radiat Oncol; 2017 Aug; 12(1):133. PubMed ID: 28810886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
